BRPI0817257A2 - Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos - Google Patents

Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos

Info

Publication number: BRPI0817257A2
Authority: BR; Brazil
Prior art keywords: monoclonal antibodies; respiratory syncytial; syncytial virus; virus; respiratory
Prior art date: 2007-09-24

Application number

BRPI0817257-9A

Other languages

English (en)

Inventor

James E Crowe Jr

Original Assignee

Univ Vanderbilt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-24

Filing date

2008-09-23

Publication date

2015-06-16

2008-09-23 Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt

2015-06-16 Publication of BRPI0817257A2 publication Critical patent/BRPI0817257A2/pt

Classifications

- C07K16/11—
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BRPI0817257-9A 2007-09-24 2008-09-23 Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos BRPI0817257A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US97467307P	2007-09-24	2007-09-24
PCT/US2008/077370 WO2009042589A1 (en)	2007-09-24	2008-09-23	Monoclonal antibodies to respiratory syncytial virus and uses thereof

Publications (1)

Publication Number	Publication Date
BRPI0817257A2 true BRPI0817257A2 (pt)	2015-06-16

Family

ID=40170637

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817257-9A BRPI0817257A2 (pt)	2007-09-24	2008-09-23	Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos

Country Status (6)

Country	Link
US (1)	US7867497B2 (pt)
EP (1)	EP2201040A1 (pt)
AU (1)	AU2008304574A1 (pt)
BR (1)	BRPI0817257A2 (pt)
CA (1)	CA2704134A1 (pt)
WO (1)	WO2009042589A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2553440T3 (es)	2009-08-13	2015-12-09	Crucell Holland B.V.	Anticuerpos contra el virus sincitial respiratorio humano (VSR) y método de uso
CA3067609A1 (en)	2009-09-03	2011-03-10	Merck Sharp & Dohme Corp.	Anti-gitr antibodies
CN103097412B (zh)	2010-07-09	2016-08-10	克鲁塞尔荷兰公司	抗人呼吸道合胞病毒(rsv)抗体以及使用方法
US11644471B2 (en)	2010-09-30	2023-05-09	Ablynx N.V.	Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
EP2621953B1 (en)	2010-09-30	2017-04-05	Ablynx N.V.	Biological materials related to c-met
US20150344568A1 (en) *	2011-06-23	2015-12-03	Ablynx N.V.	Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
PH12022550311A1 (en)	2011-06-23	2023-01-23	Ablynx Nv	Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
IN2014CN00414A (pt)	2011-06-23	2015-04-03	Ablynx Nv
KR20140082824A (ko) *	2011-10-17	2014-07-02	리제너론 파아마슈티컬스, 인크.	제한된 면역글로불린 중쇄 마우스
RU2656155C2 (ru)	2012-06-12	2018-05-31	Регенерон Фармасьютикалз, Инк.	Гуманизированные не относящиеся к человеку животные с ограниченными локусами тяжелой цепи иммуноглобулина
JO3555B1 (ar)	2015-10-29	2020-07-05	Merck Sharp & Dohme	جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
BR112019008063A2 (pt)	2016-10-21	2019-07-02	Adimab, Llc	anticorpos contra o vírus sincicial anti-respiratório e métodos de sua geração e uso
EP3974447A3 (en)	2016-10-21	2022-09-07	Adimab, LLC	Anti-respiratory syncytial virus antibodies, and methods of their generation and use
JP7265984B2 (ja)	2016-10-21	2023-04-27	アディマブ，エルエルシー	抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
WO2021202463A1 (en)	2020-03-30	2021-10-07	Danisco Us Inc	Anti-rsv antibodies
WO2025104604A1 (en)	2023-11-14	2025-05-22	Janssen Pharmaceuticals, Inc.	Anti-respiratory syncytial virus antibodies and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5859205A (en) *	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
US5824307A (en) *	1991-12-23	1998-10-20	Medimmune, Inc.	Human-murine chimeric antibodies against respiratory syncytial virus
US5639641A (en) *	1992-09-09	1997-06-17	Immunogen Inc.	Resurfacing of rodent antibodies
US6685942B1 (en) *	1993-12-10	2004-02-03	The Scripps Research Institute	Human neutralizing monoclonal antibodies to respiratory syncytial virus
US6491916B1 (en) *	1994-06-01	2002-12-10	Tolerance Therapeutics, Inc.	Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
US6180377B1 (en) *	1993-06-16	2001-01-30	Celltech Therapeutics Limited	Humanized antibodies
GB9325182D0 (en) *	1993-12-08	1994-02-09	T Cell Sciences Inc	Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
US5922344A (en) *	1995-02-10	1999-07-13	Abbott Laboratories	Product for prevention of respiratory virus infection and method of use
US5811524A (en) *	1995-06-07	1998-09-22	Idec Pharmaceuticals Corporation	Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
CA2230116A1 (en) *	1995-09-18	1997-03-27	Intracel Corporation	Neutralizing monoclonal antibodies to respiratory syncytial virus
JP4992068B2 (ja) *	2000-01-27	2012-08-08	メディミューン，エルエルシー	超高親和性中和抗体
US6855493B2 (en) *	2000-11-28	2005-02-15	Medimmune, Inc.	Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6818216B2 (en) *	2000-11-28	2004-11-16	Medimmune, Inc.	Anti-RSV antibodies
EP1597280B2 (en)	2003-02-26	2016-08-24	Institute for Research in Biomedicine	Monoclonal antibody production by ebv transformation of b cells
CA2580921C (en)	2004-09-21	2016-04-12	Medimmune, Inc.	Antibodies against and methods for producing vaccines for respiratory syncytial virus
TW200636064A (en) *	2004-10-28	2006-10-16	Centocor Inc	Anti-respiratory syncytial virus antibodies, antigens and uses thereof
US20100040606A1 (en)	2006-03-06	2010-02-18	Symphogen A/S	Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
EP1997830A1 (en)	2007-06-01	2008-12-03	AIMM Therapeutics B.V.	RSV specific binding molecules and means for producing them

2008
- 2008-09-23 WO PCT/US2008/077370 patent/WO2009042589A1/en not_active Ceased
- 2008-09-23 BR BRPI0817257-9A patent/BRPI0817257A2/pt not_active IP Right Cessation
- 2008-09-23 CA CA2704134A patent/CA2704134A1/en not_active Abandoned
- 2008-09-23 EP EP08834259A patent/EP2201040A1/en not_active Withdrawn
- 2008-09-23 US US12/236,245 patent/US7867497B2/en not_active Expired - Fee Related
- 2008-09-23 AU AU2008304574A patent/AU2008304574A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2008304574A1 (en)	2009-04-02
WO2009042589A1 (en)	2009-04-02
US7867497B2 (en)	2011-01-11
US20090092609A1 (en)	2009-04-09
EP2201040A1 (en)	2010-06-30
CA2704134A1 (en)	2009-04-02

Publication	Publication Date	Title
BRPI0817257A2 (pt)	2015-06-16	Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos
BRPI0819909A2 (pt)	2017-12-19	anticorpos antimesotelina e usos dos mesmos
IL288203A (en)	2022-01-01	Meditopes and meditope-binding antibodies and uses thereof
IL217977A (en)	2016-06-30	Antibodies against human respiratory syncytial virus (rsv) and methods of use
BRPI0912198A2 (pt)	2019-09-24	anticorpos anti-fn14 e usos dos mesmos
BRPI1009455A2 (pt)	2016-03-01	anticorpos anti-c40 e usos dos mesmos
IL223424B (en)	2018-11-29	Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
BRPI0921569A2 (pt)	2019-09-24	anticorpos para il-6 e uso dos mesmos
PT2427212T (pt)	2017-11-20	Anticorpos anti-cd100 e métodos para utilização dos mesmos
IL287311A (en)	2021-12-01	Antibodies and processes for preparing the same
BRPI0817812A2 (pt)	2015-04-14	Uso de anticorpos trkb para o tratamento de distúrbios respiratórios
IL239023A0 (en)	2015-07-30	Neutralizing antibodies to influenza viruses
BRPI0913656A2 (pt)	2019-09-24	anticorpos anti-cdh3 marcados com marcador radioisótopo e usos dos mesmos
BRPI0815983A2 (pt)	2018-05-22	anticorpos anti-cxcr5 humanizados, derivados dos mesmos e seus usos
BRPI1014016A2 (pt)	2016-09-13	anticorpos humanizados para receptor tipo toll 2 e usos dos mesmos.
BR112013013781A2 (pt)	2016-09-13	anticorpos humanizados para liv-1 e uso dos mesmos para tratar câncer
BRPI0717638A2 (pt)	2013-11-12	Anticorpors e imunoconjugados e usos para os mesmos
BRPI0812005A2 (pt)	2019-09-24	anticorpos humanizados para o globulômeros de ab(20-42) e seus usos.
BRPI0818677A2 (pt)	2015-04-14	Anticorpos que se ligam à il-4 e/ou il-13, composições farmacêuticas compreendendo os referidos anticorpos, bem como usos dos mesmos
BR112013024493A2 (pt)	2018-06-26	cristais de anticorpo antiesclerostina e formulações dos mesmos
PL2474557T3 (pl)	2015-02-27	Przeciwciała anty- CD79b i immunokoniugaty i sposoby stosowania
PT2424896E (pt)	2015-11-30	Anticorpos anti-ceacam1 e métodos de utilização dos mesmos
BR112014011304A2 (pt)	2017-05-16	anticorpos de ligação com albumina e fragmentos de ligação dos mesmos
ZA201004478B (en)	2011-12-28	Antibodies against influenza virus and methods of use thereof
PL2710033T3 (pl)	2021-10-25	Przeciwciała neutralizujące ludzkiego wirusa niedoboru odporności i sposoby ich stosowania

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.